Find the latest and updated news related to Glibenclamide aggregated by PharmaCompass.com.

Glibenclamide
News
Full Screen View

Glibenclamide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers, 16 USDMF, 9 CEP/COS, 4 JDMF, 6 EU WC, 1 KDMF, 6 NDC API, 12 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

184 Dossiers, 83 FDA Orange Book, 29 Europe, 9 Canada, 1 Australia, 19 South Africa, 43 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 1.25MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 27 BASF, 18 Roquette, 14 Corel Pharma Chem, 13 Seppic, 13 Microlex e.U, 12 Sigachi Industries, 11 Gangwal Chemicals, 9 Gangwal Healthcare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 SPI Pharma, 7 DFE Pharma, 6 Boai NKY Pharmaceuticals Ltd, 6 Lonza Capsugel, 6 Nanjing Well Pharmaceutical, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Ideal Cures Pvt Ltd, 5 Actylis, 4 Prachin Chemical, 4 Vasa Pharmachem, 4 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Pharmatrans-Sanaq, 3 DKSH, 3 Ulanqab Kema New Material, 2 The Dow Chemical Company, 2 Aeon Procare, 2 Seqens, 2 Finar, 2 Clariant, 2 Evonik, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 1 Qualicaps, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Nanjing Bold Chemical, 1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 38 Controlled & Modified Release, 38 Direct Compression, 31 Disintegrants & Superdisintegrants, 28 Solubilizers, 25 Granulation, 24 Thickeners and Stabilizers, 19 Film Formers & Plasticizers, 18 Lubricants & Glidants, 17 Topical, 15 Co-Processed Excipients, 14 Parenteral, 11 Taste Masking, 8 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 6 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 36 Finished Drug Prices

MARKET PLACE

14 APIs, 5 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

4 EDQM Standards, 3 USP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 21 News

SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin

FDA

15 Nov 2023

Generic Drugmaker Admits to Price Fixing

POST ENQUIRY

Find the latest and updated news related to Glibenclamide aggregated by PharmaCompass.com.

Glibenclamide News Full Screen View

Glibenclamide

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers

16 USDMF

9 CEP/COS

4 JDMF

6 EU WC

1 KDMF

6 NDC API

12 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

184 Dossiers

83 FDA Orange Book

29 Europe

9 Canada

1 Australia

19 South Africa

43 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 1.25MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 5MG

TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

27 BASF

18 Roquette

14 Corel Pharma Chem

13 Seppic

13 Microlex e.U

12 Sigachi Industries

11 Gangwal Chemicals

9 Gangwal Healthcare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 SPI Pharma

7 DFE Pharma

6 Boai NKY Pharmaceuticals Ltd

6 Lonza Capsugel

6 Nanjing Well Pharmaceutical

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Ideal Cures Pvt Ltd

5 Actylis

4 Prachin Chemical

4 Vasa Pharmachem

4 Ingredion Pharma Solutions

3 Kima Chemical

3 Pharmatrans-Sanaq

3 DKSH

3 Ulanqab Kema New Material

2 The Dow Chemical Company

2 Aeon Procare

2 Seqens

2 Finar

2 Clariant

2 Evonik

2 Jai Radhe Sales

2 Nomisma Healthcare

1 Qualicaps

1 Avesta Pharma

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

1 Huzhou Sunflower Pharmaceutical Co. Ltd

Glibenclamide
News
Full Screen View

TABLET;ORAL - 1.25MG;250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 2.5MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons